Generalised epilepsy

Results: 209



#Item
1SOUTH BRUNSWICK BOARD OF EDUCATION Seizure Health Care/Emergency Plan and Medication Orders Student Name_____________________________________________ Date of Birth________________ Age_________ Weight__________ School ___

SOUTH BRUNSWICK BOARD OF EDUCATION Seizure Health Care/Emergency Plan and Medication Orders Student Name_____________________________________________ Date of Birth________________ Age_________ Weight__________ School ___

Add to Reading List

Source URL: www.sbschools.org

Language: English - Date: 2014-06-13 12:02:40
2Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2016-08-04 23:27:08
3Microsoft PowerPoint - CNA certification lecture format for OTN Jan 2013.pptx [Read-Only]

Microsoft PowerPoint - CNA certification lecture format for OTN Jan 2013.pptx [Read-Only]

Add to Reading List

Source URL: swostroke.ca

Language: English - Date: 2015-07-06 16:01:15
4Articles  Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials Philippe Ryvlin*, Michel Cuchera

Articles Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials Philippe Ryvlin*, Michel Cuchera

Add to Reading List

Source URL: emoryneurology.files.wordpress.com

Language: English - Date: 2016-06-13 16:36:20
5LeadingAge Minnesota 2015 Institute and Expo Session #411- Treating Seizure Disorders in Older Adults Thursday, February 12- 2:30pm Presenter: Amanda Pike, Program Manager Education

LeadingAge Minnesota 2015 Institute and Expo Session #411- Treating Seizure Disorders in Older Adults Thursday, February 12- 2:30pm Presenter: Amanda Pike, Program Manager Education

Add to Reading List

Source URL: institute.leadingagemn.org

Language: English - Date: 2015-02-01 15:54:42
6Epilepsy is a common brain disease characterized by the recurrent occurrence of spontaneous seizures that affects an estimated 50 million people worldwide. The prevalence of epilepsy is estimated at 4-7 per 1,000 persons

Epilepsy is a common brain disease characterized by the recurrent occurrence of spontaneous seizures that affects an estimated 50 million people worldwide. The prevalence of epilepsy is estimated at 4-7 per 1,000 persons

Add to Reading List

Source URL: brainfoundation.org.au

Language: English - Date: 2014-10-28 10:52:34
7Epilepsy Epilepsy is a group of neurological disorders, characterized by recurrent seizures – brief periods of uncontrolled electrical activity in the brain, which may last a few seconds to a few minutes. Epilepsy affe

Epilepsy Epilepsy is a group of neurological disorders, characterized by recurrent seizures – brief periods of uncontrolled electrical activity in the brain, which may last a few seconds to a few minutes. Epilepsy affe

Add to Reading List

Source URL: brainfoundation.org.au

Language: English - Date: 2014-10-28 10:52:40
8What is Epilepsy? Epilepsy is a common neurological disorder that manifests itself as fits or seizures. It is characterised by abnormal electrical activity in the brain and is associated with sudden recurrent episodes of

What is Epilepsy? Epilepsy is a common neurological disorder that manifests itself as fits or seizures. It is characterised by abnormal electrical activity in the brain and is associated with sudden recurrent episodes of

Add to Reading List

Source URL: brainfoundation.org.au

Language: English - Date: 2014-10-28 10:52:40
9PUBLIC SUMMARY DOCUMENT Product: Lacosamide, tablets, 50 mg, 100 mg, 150 mg and 200 mg, Vimpat® Sponsor: UCB Australia Pty Ltd Date of PBAC Consideration: NovemberPurpose of Application

PUBLIC SUMMARY DOCUMENT Product: Lacosamide, tablets, 50 mg, 100 mg, 150 mg and 200 mg, Vimpat® Sponsor: UCB Australia Pty Ltd Date of PBAC Consideration: NovemberPurpose of Application

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:56:22
10Clinical comparison of primary versus secondary epilepsy in 125 cats

Clinical comparison of primary versus secondary epilepsy in 125 cats

Add to Reading List

Source URL: www.2ndchance.info

Language: English - Date: 2014-02-04 17:35:23